Literature DB >> 26977281

Opioid-induced constipation: advances and clinical guidance.

Alfred D Nelson1, Michael Camilleri2.   

Abstract

Currently opioids are the most frequently used medications for chronic noncancer pain. Opioid-induced constipation is the most common adverse effect associated with prolonged use of opioids, having a major impact on quality of life. There is an increasing need to treat opioid-induced constipation. With the recent approval of medications for the treatment of opioid-induced constipation, there are several therapeutic approaches. This review addresses the clinical presentation and diagnosis of opioid-induced constipation, barriers to its diagnosis, effects of opioids in the gastrointestinal tract, differential tolerance to opiates in different gastrointestinal organs, medications approved and in development for the treatment of opioid-induced constipation, and a proposed clinical management algorithm for treating opioid-induced constipation in patients with noncancer pain.

Entities:  

Keywords:  lubiprostone; methylnaltrexone; naloxegol; noncancer pain; peripheral µ opioid receptor antagonist; tolerance

Year:  2016        PMID: 26977281      PMCID: PMC4772344          DOI: 10.1177/2040622315627801

Source DB:  PubMed          Journal:  Ther Adv Chronic Dis        ISSN: 2040-6223            Impact factor:   5.091


  87 in total

Review 1.  Incidence, prevalence, and management of opioid bowel dysfunction.

Authors:  M Pappagallo
Journal:  Am J Surg       Date:  2001-11       Impact factor: 2.565

2.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

3.  The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health.

Authors:  B S Wong; A S Rao; M Camilleri; N Manabe; S McKinzie; I Busciglio; D D Burton; M Ryks; A R Zinsmeister
Journal:  Aliment Pharmacol Ther       Date:  2010-10       Impact factor: 8.171

Review 4.  Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review.

Authors:  Jan Gaertner; Waldemar Siemens; Michael Camilleri; Andrew Davies; Douglas A Drossman; Lynn R Webster; Gerhild Becker
Journal:  J Clin Gastroenterol       Date:  2015-01       Impact factor: 3.062

5.  Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model.

Authors:  G S Ling; D Paul; R Simantov; G W Pasternak
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

6.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

7.  A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.

Authors:  Winfried Meissner; Petra Leyendecker; Stefan Mueller-Lissner; Joachim Nadstawek; Michael Hopp; Christian Ruckes; Stefan Wirz; Wolfgang Fleischer; Karen Reimer
Journal:  Eur J Pain       Date:  2008-08-31       Impact factor: 3.931

8.  The effect of loperamide on anorectal function in normal healthy men.

Authors:  F Musial; P Enck; K T Kalveram; J F Erckenbrecht
Journal:  J Clin Gastroenterol       Date:  1992-12       Impact factor: 3.062

9.  SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents.

Authors:  John Cuppoletti; Danuta H Malinowska; Kirti P Tewari; Qiu-Ju Li; Ann M Sherry; Myra L Patchen; Ryuji Ueno
Journal:  Am J Physiol Cell Physiol       Date:  2004-06-22       Impact factor: 4.249

10.  The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity.

Authors:  Scott R Armstrong; Christina B Campbell; Carrie L Richardson; Ross G Vickery; Pamela R Tsuruda; Daniel D Long; Sharath S Hegde; David T Beattie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-13       Impact factor: 3.000

View more
  26 in total

1.  Synthesis and opioid receptor binding of indium (III) and [111In]-labeled macrocyclic conjugates of diprenorphine: novel ligands designed for imaging studies of peripheral opioid receptors.

Authors:  Shefali Srivastava; Emily A Fergason-Cantrell; Roger I Nahas; John R Lever
Journal:  Tetrahedron       Date:  2016-08-04       Impact factor: 2.457

Review 2.  Pathophysiology and management of opioid-induced constipation: European expert consensus statement.

Authors:  Adam D Farmer; Asbjørn M Drewes; Giuseppe Chiarioni; Roberto De Giorgio; Tony O'Brien; Bart Morlion; Jan Tack
Journal:  United European Gastroenterol J       Date:  2018-12-14       Impact factor: 4.623

Review 3.  American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation.

Authors:  Brian Hanson; Shazia Mehmood Siddique; Yolanda Scarlett; Shahnaz Sultan
Journal:  Gastroenterology       Date:  2018-10-16       Impact factor: 22.682

Review 4.  The role of naloxegol in the management of opioid-induced bowel dysfunction.

Authors:  Wojciech Leppert; Jaroslaw Woron
Journal:  Therap Adv Gastroenterol       Date:  2016-05-26       Impact factor: 4.409

Review 5.  Opioid misuse in gastroenterology and non-opioid management of abdominal pain.

Authors:  Eva Szigethy; Mitchell Knisely; Douglas Drossman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-15       Impact factor: 46.802

6.  Formulary Drug Review: Naldemedine.

Authors:  Danial E Baker
Journal:  Hosp Pharm       Date:  2017-08-09

Review 7.  Targeting Small Bowel Receptors to Treat Constipation and Diarrhea.

Authors:  Elizabeth S John; Sita Chokhavatia
Journal:  Curr Gastroenterol Rep       Date:  2017-07

8.  More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer.

Authors:  Eric J Roeland; Christopher J Sera; Joseph D Ma
Journal:  Support Care Cancer       Date:  2019-07-22       Impact factor: 3.603

9.  Naldemedine (Symproic) for the Treatment Of Opioid-Induced Constipation.

Authors:  Kenneth Hu; Mary Barna Bridgeman
Journal:  P T       Date:  2018-10

10.  Validity and Reliability of the Hindi Version of the Patient Assessment of Constipation Quality of Life Questionnaire in Cancer Patients on Opioids for Pain Management at Tertiary Care Center, India.

Authors:  Seema Mishra; Ram Singh; Sujata Satapathy; Sushma Bhatnagar
Journal:  Indian J Palliat Care       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.